GLP-1, GIP and glucagon receptor agonists studied for metabolic and energy-expenditure research. Includes Retatrutide (triple agonist), Tirzepatide (dual agonist), MOTS-c and AOD-9604. Among the most active research areas in contemporary metabolic science. All compounds HPLC-verified, research use only. All compounds are HPLC-tested and supplied strictly for laboratory research.
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Same Day Dispatch
A dual GIP and GLP-1 receptor agonist studied in metabolic and glucoregulatory research.
Dispatch Within 5 Days
Join the Pepreta research list for new product drops, third-party COA releases and members-only pricing. No spam — unsubscribe anytime.